2019 International Congress Archives - Page 171 of 217

Rivastigmine for visual hallucinations in Parkinson’s disease

T. Mierlo, E. Foncke, R. Bie (Amsterdam, Netherlands)
RNA binding protein mediated regulation of striatal transcriptome in Parkinson’s disease.

K. Irmady, C. Hale, C. Scheckel, J. Fak, R. Darnell (New York, NY, USA)
Role of Alzheimer’s Disease Genetic Risk Variant rs9331896 in Cognitive Decline in Parkinson’s Disease

T. Tropea, L. Baratta, K. Maddy, M. Guo, J. Rick, V. van Deerlin, J. Trojanowski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)
Role of APOE ε4 status and Sex on Somatosensory Integration and Dual-Task Cost in Parkinson’s disease

D. Martini, R. Morris, G. Mcbarron, T. Madhyastha, T. Grabowski, SC. Hu, C. Zabetian, A. Hiller, K. Chung, J. Quinn, F. Horak (Portland, OR, USA)
Role of clinical neuroimaging in X-linked dystonia-parkinsonism

J. Junker, A. Neumann, R. Rosales, D. Jamora, C. Diesta, J. Prasuhn, T. Muente, C. Klein, P. Schramm, N. Brueggemann (Luebeck, Germany)
Role of microRNA-153 and -223 in Parkinson disease

M. Cressatti, W. Song, L. Jawura, J. Galindez, O. Canie, A. Velly, M. Gornitsky, H. Schipper (Montreal, QC, Canada)
Role of pallidotomy in secondary dystonia in pediatric patients

K. Garg, M. Singh, V. Goyal (New Delhi, India)
rTMS-induced effects on Functional Tremor: a randomized, double-blind, controlled study

S. Taib, F. Ory-Magne, C. Brefel-Courbon, Y. Moreau, C. Thalamas, C. Arbus, M. Simonetta-Moreau (Toulouse, France)
Saccade profiles in Tourette syndrome

Y. Sugiyama, H. Fukuda, Y. Terao, S. Tokushige, K. Hoshino, M. Hamada, Y. Ugawa, T. Toda (Tokyo, Japan)
Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson’s disease : a large single-center study

A-S. Blaise, G. Baille, N. Carrière, D. Devos, K. Dujardin, G. Grolez, A. Kreisler, M. Kyheng, C. Moreau, E. Mutez, D. Seguy, L. Defebvre (Lille, France)